Irvine, CA, United States of America

Minglei Cui

This inventor holds 16 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents, primarily in Pain Management. Top assignees: Allergan, Inc., Allergan Sales, Inc.. Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minglei Cui. Retrieved from https://idiyas.com/inventor/minglei-cui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 87.5



Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 354(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neuropathic Pain
Trigeminal Neuralgia
Neurotoxin
Allodynia
Phantom Pain
Hyperalgesia
Burn Pain
Post-operative Pain
Botulinum Toxin
Intraspinal Treatment
Modified Neurotoxin
Facial Pain
16 patents (USPTO):Explore Patents

Title: Minglei Cui: Innovator in Neuropathic Pain Treatment

Introduction

Minglei Cui is a prominent inventor based in Irvine, California, known for his significant contributions to the field of neuropathic pain treatment. With a total of 16 patents to his name, Cui has made remarkable advancements in medical methodologies that aim to alleviate pain through innovative techniques.

Latest Patents

Cui's latest patents include a neuropathic pain treatment method that focuses on treating non-spasm caused pain through the peripheral administration of a therapeutically effective amount of a neurotoxin, such as botulinum toxin. Another notable patent is a method for treating trigeminal neuralgia, which also involves the peripheral administration of a neurotoxin to provide relief to patients suffering from this debilitating condition.

Career Highlights

Throughout his career, Minglei Cui has worked with reputable companies, including Allergan, Inc. and Allergan Sales, Inc. His work in these organizations has allowed him to develop and refine his innovative approaches to pain management, contributing to the advancement of medical treatments.

Collaborations

Cui has collaborated with esteemed colleagues such as Kei Roger Aoki and Stephen W. Jenkins, further enhancing the impact of his work in the medical field.

Conclusion

Minglei Cui's dedication to innovation in neuropathic pain treatment has led to significant advancements in medical methodologies. His contributions continue to influence the field and provide hope for patients suffering from chronic pain conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…